RENALSENSE

RenalSense is dedicated to real-time renal diagnostics. The company's first product, Clarity RMS, is a critical care digital monitoring system for early detection of changes in renal function and acute kidney injury (AKI) risk. Continuous, electronic, real-time urine flow data digitizes one of the only vital signs still measured manually and inefficiently, allowing faster diagnosis and earlier intervention to preserve kidney function. With over 50% of ICU patients developing AKI, RenalSense's approach promises to introduce a new standard of care across the world... Renal function monitoring is critical for early detection of changes and prevention of disease progression.

Also known as: RenalSense Ltd., RENALSENSE UK

Registration numbers: FC040020 (CH)

Primary location: Jerusalem Israel